pH-Responsive Nano Carriers for Doxorubicin Delivery
Authors:
- 7 October 2014
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 32 (4) , 1249-1263
Abstract
The aim of this study was to design stimuli-responsive nanocarriers for anti-cancer drug delivery. For this purpose, doxorubicin (DOX)-loaded, polysebacic anhydride (PSA) based nanocapsules (NC) were combined with pH-sensitive poly (L-histidine) (PLH).Keywords
This publication has 40 references indexed in Scilit:
- How does doxorubicin work?eLife, 2012
- Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1eLife, 2012
- Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapyInternational Journal of Nanomedicine, 2012
- Poly(L‐histidine)‐chitosan/alginate complex microcapsule as a novel drug delivery agentJournal of Applied Polymer Science, 2011
- Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticlesInternational Journal of Nanomedicine, 2011
- Polyanionic carbohydrate doxorubicin–dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluationsInternational Journal of Nanomedicine, 2011
- Doxorubicin pathwaysPharmacogenetics and Genomics, 2011
- Doxorubicin‐Loaded Polymeric Micelle Overcomes Multidrug Resistance of Cancer by Double‐Targeting Folate Receptor and Early Endosomal pHSmall, 2008
- Cytotoxicity of 5-fluorouracil entrapped in gelatin microspheresJournal of Microencapsulation, 2004
- Poly-L-histidineJournal of the American Chemical Society, 1957